ReviewAnnals of medicine and surgery (2012)2025
Global trends and prospects of endothelial keratoplasty from 2004 to 2023: a bibliometric analysis.
Review in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Endothelial keratoplasty (EK) has revolutionized the treatment of corneal diseases by offering a less invasive alternative to traditional full-thickness keratoplasty. Over the past decades, EK techniques have evolved significantly, improving surgical outcomes, expediting recovery, and reducing postoperative complications. Nevertheless, challenges such as postoperative rejection and endothelial cell loss persist. This study utilizes bibliometric analysis to map the current research landscape of EK and identify future directions. Methods: A systematic bibliometric analysis was conducted on publications spanning from 2004 to 2023, retrieved from the Web of Science Core Collection. Key metrics such as annual publication and citation counts, contributions by countries and institutions, influential journals, authors and cited authors, highly cited references, co-citation references, and keyword trends were extracted and analyzed using CiteSpace and VOSviewer, Microsoft Excel, Bibliometrix, Scimago Graphica, and Microsoft Excel. Results: A total of 2676 relevant publications were identified from 2004 to 2023. While the first 5 years saw the limited number of publications in this field, a marked increase in publications has occurred throughout these years. The United States, Germany, and England were the leading contributors. Marianne O. Price emerged as the most prolific author, with Francis W. Price Jr. most frequently cited among the top contributors. Major publishing journals included Conclusions: The bibliometric analysis highlights the dynamic evolution and key research areas of EK and ocular disease management. Leveraging these insights is crucial for advancing clinical practice and driving further innovation in the field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.